SEC Form 4 · accession 0001562180-19-001844
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey B Kindler
Officer — Executive Chairman · Director
Period of report
Mar 10, 2019
Accepted (ET)
Mar 11, 2019 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Mar 10, 2019 | M | 11,666 | $0.00 | A | 23,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Mar 10, 2019 | M | 11,666 | D | — | Mar 10, 2020 | Class A Common Stock | 11,666 | 11,667 | D |
Explanation of responses
- F1Represents shares of Class A common stock issued upon vesting of 33.33% of the restricted stock units granted March 10, 2017.
- F2Each restricted stock unit represents a contingent right to receive one share of vTv Therapeutics Inc. Class A Common Stock
- F3The restricted stock units were granted on March 10, 2017 and vest in three equal installments beginning March 10, 2018.